Global Metabolomics Market to Grow at 12% CAGR by 2027 The latest research study "
Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the
global metabolomics market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2027, exhibiting a CAGR of 12% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Metabolomics refers to the study of metabolites, small molecule substrates, intermediates and products of metabolism. It is used for phenotyping of genetically modified plants, identifying gene function and analyzing biotic-abiotic stress reaction. It helps researchers and scientists in calculating the physiological effects and metabolism of drugs. At present, the demand for metabolomics is escalating as it offers an assessment of health as well as causes and treatment of different medical ailments.
Global Metabolomics Industry Trends and Drivers: The thriving healthcare industry is one of the key factors driving the market growth. In line with this, metabolomics is extensively employed in the healthcare industry for the discovery and optimization of a lead compound and identification of biomarkers, which is contributing to the market growth significantly. Apart from this, the increasing demand for personalized medicines and technological advancements in analytical techniques is further bolstering the market growth. Other factors, such as the growing geriatric population and rising investments by governments of several countries on healthcare infrastructure, are expected to drive the market in the upcoming years.
List of Major Key Players:
The major players in the market are Agilent Technologies, Inc. (A), Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc. (BIO), Bruker Corporation (BRKR), Danaher Corporation (DHR), HUMAN METABOLOME TECHNOLOGIES I (6090.T), Metabolon Inc., SHIMADZU CORP (SHMZF), Thermo Fisher Scientific Inc., Waters Corporation, etc.
Explore full report with table of contents: https://www.imarcgroup.com/metabolomics-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US: IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group